Nebulizer
Latest Novartis AG Patents:
- Tricyclic AKR1C3 dependent KARS inhibitors
- Treatment of cancer using GFR alpha-4 chimeric antigen receptor
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant FC fusion proteins
- Solid forms comprising an oxime ether compound, compositions and methods of use thereof
- Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors
Description
The broken line showing in
Claims
The ornamental design for a nebulizer, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
D441069 | April 24, 2001 | Hammarlund et al. |
6578571 | June 17, 2003 | Watt |
7418962 | September 2, 2008 | Rao |
20050217666 | October 6, 2005 | Fink et al. |
WO 2007/024812 | March 2007 | WO |
Patent History
Patent number: D591418
Type: Grant
Filed: Apr 10, 2008
Date of Patent: Apr 28, 2009
Assignee: Novartis AG (Basel)
Inventor: Glenn M. White (Felton, CA)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Michael Mazza
Application Number: 29/307,282
Type: Grant
Filed: Apr 10, 2008
Date of Patent: Apr 28, 2009
Assignee: Novartis AG (Basel)
Inventor: Glenn M. White (Felton, CA)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Michael Mazza
Application Number: 29/307,282
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)